Literature DB >> 29088328

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

Jean-Philippe Collet, Marco Roffi, Robert A Byrne, Francesco Costa, Marco Valgimigli.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29088328     DOI: 10.1093/eurheartj/ehx503

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short.

Authors:  Francesco Costa; Marco Valgimigli
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

2.  Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis.

Authors:  Leiling Liu; Hao Lei; Jiahui Hu; Ying Tang; Danyan Xu
Journal:  Drugs       Date:  2021-11-03       Impact factor: 9.546

Review 3.  Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.

Authors:  Alessandro Caracciolo; Renato Francesco Maria Scalise; Fabrizio Ceresa; Gianluca Bagnato; Antonio Giovanni Versace; Roberto Licordari; Silvia Perfetti; Francesca Lofrumento; Natasha Irrera; Domenico Santoro; Francesco Patanè; Gianluca Di Bella; Francesco Costa; Antonio Micari
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

4.  Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease.

Authors:  Susu Jin; Xiujing Liu; Yingying Wang; Jian Yu; Minghua Jiang
Journal:  J Clin Lab Anal       Date:  2021-11-19       Impact factor: 2.352

5.  Impacts of Omaha System-Based Continuing Care on the Medication Compliance, Quality of Life, and Prognosis of Coronary Heart Disease Patients After PCI.

Authors:  Sijuan Yin; Yangyi Ou; E Ting
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.